{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:58:54Z","timestamp":1781308734290,"version":"3.54.1"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.phrs.2017.02.023","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T23:18:48Z","timestamp":1488842328000},"page":"391-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor"],"prefix":"10.1016","volume":"119","author":[{"given":"Silvia","family":"Marino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymen I.","family":"Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.02.023_bib0005","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1038\/sj.bjp.0706406","article-title":"Cannabinoid pharmacology: the first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1126\/science.311.5759.322","article-title":"Drug development. Drugs inspired by a drug","volume":"311","author":"Marx","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.phrs.2017.02.023_bib0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Di Marzo","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2017.02.023_bib0020","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1046\/j.1432-1033.2002.03078.x","article-title":"Presence and regulation of the endocannabinoid system in human dendritic cells","volume":"269","author":"Matias","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.phrs.2017.02.023_bib0025","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bjp.0706415","article-title":"Plant cannabinoids: a neglected pharmacological treasure trove","volume":"146","author":"Mechoulam","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0030","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrd2553","article-title":"Targeting the endocannabinoid system: to enhance or reduce?","volume":"7","author":"Di Marzo","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2017.02.023_bib0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2017.02.023_bib0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/er.2005-0009","article-title":"The emerging role of the endocannabinoid system in endocrine regulation and energy balance","volume":"27","author":"Pagotto","year":"2006","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.phrs.2017.02.023_bib0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4103\/0975-7406.84435","article-title":"Endocannabinoid system in cardiovascular disorders \u2013 new pharmacotherapeutic opportunities","volume":"3","author":"Cunha","year":"2011","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.phrs.2017.02.023_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2016.02.008","article-title":"Cannabinoids and autoimmune diseases: a systematic review","author":"Katchan","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2017.02.023_bib0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.phrs.2017.02.023_bib0060","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1476-5381.2012.01950.x","article-title":"Monoacylglycerol lipase \u2013 a target for drug development?","volume":"166","author":"Fowler","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0065","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/hmg\/ddi370","article-title":"Cannabinoid receptor type 2 gene is associated with human osteoporosis","volume":"14","author":"Karsak","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2017.02.023_bib0070","first-page":"1","article-title":"Pharmacological actions of cannabinoids","author":"Pertwee","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","article-title":"Is lipid signaling through cannabinoid 2 receptors part of a protective system?","volume":"50","author":"Pacher","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.02.023_bib0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","article-title":"Cannabinoid receptors: where they are and what they do","volume":"20","author":"Mackie","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2009.03.019","article-title":"Endocannabinoids and immune regulation","volume":"60","author":"Pandey","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0100","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.imbio.2009.04.001","article-title":"Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression","volume":"215","author":"Rieder","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.phrs.2017.02.023_bib0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainresrev.2008.12.003","article-title":"Targeting CB2 receptors and the endocannabinoid system for the treatment of pain","volume":"60","author":"Anand","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.phrs.2017.02.023_bib0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12035-007-8007-7","article-title":"Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain","volume":"36","author":"Jhaveri","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/157015906778019527","article-title":"Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes","volume":"4","author":"Manzanares","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0120","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral cannabinoid receptor, CB2, regulates bone mass","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2017.02.023_bib0125","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1210\/en.2008-0150","article-title":"Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor","volume":"149","author":"Idris","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2017.02.023_bib0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12026-011-8210-5","article-title":"Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease","volume":"51","author":"Basu","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0135","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm1255","article-title":"Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors","volume":"11","author":"Idris","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2017.02.023_bib0140","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bone.2008.10.056","article-title":"The endovanilloid\/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption","volume":"44","author":"Rossi","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2017.02.023_bib0145","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1111\/j.1476-5381.2011.01519.x","article-title":"Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro","volume":"165","author":"Whyte","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0150","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/mol.106.026435","article-title":"Involvement of neuronal cannabinoid receptor, CB1, in regulation of bone mass and bone remodeling","volume":"70","author":"Tam","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1096\/fj.06-7957com","article-title":"The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling","volume":"22","author":"Tam","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2017.02.023_bib0160","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bone.2011.01.001","article-title":"The endovanilloid\/endocannabinoid system: a new potential target for osteoporosis therapy","volume":"48","author":"Rossi","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2017.02.023_bib0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1874473710902010051","article-title":"Phytocannabinoids and endocannabinoids","volume":"2","author":"Fisar","year":"2009","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.phrs.2017.02.023_bib0170","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/1389557054368844","article-title":"CB2 receptor ligands","volume":"5","author":"Huffman","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.02.023_bib0175","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/sj.ijo.0803271","article-title":"Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake","volume":"30","author":"Matias","year":"2006","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.phrs.2017.02.023_bib0180","doi-asserted-by":"crossref","first-page":"26465","DOI":"10.1074\/jbc.M604660200","article-title":"Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for \u03b1\/\u03b2-hydrolase 4 in this pathway","volume":"281","author":"Simon","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2017.02.023_bib0185","first-page":"1","article-title":"Endocannabinoids: synthesis and degradation","volume":"160","author":"Di Marzo","year":"2008","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1054\/plef.2001.0356","article-title":"Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance","volume":"66","author":"Sugiura","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.phrs.2017.02.023_bib0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/092986607780090829","article-title":"Critical enzymes involved in endocannabinoid metabolism","volume":"14","author":"Basavarajappa","year":"2007","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.phrs.2017.02.023_bib0200","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1476-5381.2012.01950.x","article-title":"Monoacylglycerol lipase \u2013 a target for drug development?","volume":"166","author":"Fowler","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2017.02.023_bib0210","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.4049\/jimmunol.1102195","article-title":"Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses","volume":"187","author":"Basu","year":"2011","journal-title":"J. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.02.023_bib0215","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/sj.ijo.0803272","article-title":"The pharmacology of cannabinoid receptors and their ligands: an overview","volume":"30","author":"Pertwee","year":"2006","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.phrs.2017.02.023_bib0220","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0026-895X(24)26516-0","article-title":"Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide","volume":"57","author":"Gonsiorek","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0225","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1074\/jbc.275.1.605","article-title":"Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells","volume":"275","author":"Sugiura","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2017.02.023_bib0230","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0235","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2174\/092986710790980050","article-title":"Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists","volume":"17","author":"Pertwee","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2017.02.023_bib0240","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/acs.chemrev.5b00411","article-title":"Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2 receptor agonists","volume":"116","author":"Aghazadeh Tabrizi","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.phrs.2017.02.023_bib0245","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bjp.0707303","article-title":"Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers","volume":"151","author":"Bingham","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0250","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cdna","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2017.02.023_bib0255","article-title":"Functional selectivity at g-protein coupled receptors: advancing cannabinoid receptors as drug targets","author":"Mallipeddi","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0260","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/taap.1996.8034","article-title":"Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system","volume":"142","author":"Schatz","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0265","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2017.02.023_bib0270","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0083-6729(02)65066-6","article-title":"Endocannabinoids and their actions","volume":"65","author":"Maccarrone","year":"2002","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.phrs.2017.02.023_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2010.02.013","article-title":"Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities","volume":"80","author":"Bosier","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0280","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc1188","article-title":"Cannabinoids: potential anticancer agents","volume":"3","author":"Guzman","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0285","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tips.2013.03.003","article-title":"The endocannabinoid signaling system in cancer","volume":"34","author":"Pisanti","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2017.02.023_bib0290","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1677\/ERC-07-0258","article-title":"Endocannabinoids in endocrine and related tumours","volume":"15","author":"Bifulco","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0295","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ctrv.2012.06.005","article-title":"Cannabinoids: a new hope for breast cancer therapy?","volume":"38","author":"Caffarel","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phrs.2017.02.023_bib0300","first-page":"49","article-title":"Molecular biology of bone remodelling","volume":"5","author":"Rucci","year":"2008","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"10.1016\/j.phrs.2017.02.023_bib0305","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Rosen","year":"2013"},{"key":"10.1016\/j.phrs.2017.02.023_bib0310","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.abb.2008.03.016","article-title":"Regulation of bone remodeling by the central and peripheral nervous system","volume":"473","author":"Elefteriou","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2017.02.023_bib0315","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1242\/jcs.063032","article-title":"Bone remodelling at a glance","volume":"124","author":"Crockett","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.phrs.2017.02.023_bib0320","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.abb.2008.03.037","article-title":"Osteoclast lineage and function","volume":"473","author":"Vaananen","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2017.02.023_bib0325","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of rankl\/rank\/opg in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2017.02.023_bib0330","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2017.02.023_bib0335","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/154405910608500703","article-title":"Bone remodeling in post-menopausal osteoporosis","volume":"85","author":"Lerner","year":"2006","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0340","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/ortho\/25.2.101","article-title":"Bone remodelling","volume":"25","author":"Hill","year":"1998","journal-title":"Br. J. Orthod."},{"key":"10.1016\/j.phrs.2017.02.023_bib0345","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrm2066","article-title":"Adipocyte differentiation from the inside out","volume":"7","author":"Rosen","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0350","first-page":"581","article-title":"Osteoblast progenitor fate and age-related bone loss","volume":"2","author":"Jilka","year":"2002","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.phrs.2017.02.023_bib0355","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1365.035","article-title":"Bone remodeling","volume":"1092","author":"Hadjidakis","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2017.02.023_bib0360","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00223-006-0171-7","article-title":"Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors","volume":"80","author":"Scutt","year":"2007","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.phrs.2017.02.023_bib0365","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/en.2010-0930","article-title":"The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation","volume":"152","author":"Sophocleous","year":"2011","journal-title":"Endocrinology"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.02.023_bib0370","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2826.2008.01675.x","article-title":"Endocannabinoids and the regulation of bone metabolism","volume":"20","author":"Bab","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0375","doi-asserted-by":"crossref","first-page":"22049","DOI":"10.1074\/jbc.M115.649608","article-title":"Bone cell-autonomous contribution of type 2 cannabinoid receptor to breast cancer-induced osteolysis","volume":"290","author":"Sophocleous","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2017.02.023_bib0380","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00223-013-9793-8","article-title":"Genetic background modifies the effects of type 2 cannabinoid receptor deficiency on bone mass and bone turnover","volume":"94","author":"Sophocleous","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.phrs.2017.02.023_bib0385","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The international hapmap project","volume":"426","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2017.02.023_bib0390","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00223-013-9823-6","article-title":"Modulation of strain-specific differences in gene expression by cannabinoid type 2 receptor deficiency","volume":"94","author":"Sophocleous","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.phrs.2017.02.023_bib0395","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1098\/rstb.2011.0381","article-title":"Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities","volume":"367","author":"Pertwee","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"key":"10.1016\/j.phrs.2017.02.023_bib0400","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1476-5381.2011.01327.x","article-title":"The endocannabinoid system and cancer: therapeutic implication","volume":"163","author":"Guindon","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0405","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nrc3247","article-title":"Towards the use of cannabinoids as antitumour agents","volume":"12","author":"Velasco","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0410","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1476-4598-9-196","article-title":"Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition","volume":"9","author":"Caffarel","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0415","doi-asserted-by":"crossref","first-page":"djv077","DOI":"10.1093\/jnci\/djv077","article-title":"Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer","volume":"107","author":"Perez-Gomez","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phrs.2017.02.023_bib0420","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/0008-5472.CAN-07-2785","article-title":"Cannabinoids for cancer treatment: progress and promise","volume":"68","author":"Sarfaraz","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0425","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pnpbp.2015.05.010","article-title":"The use of cannabinoids as anticancer agents","volume":"64","author":"Velasco","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2017.02.023_bib0430","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","article-title":"Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response","volume":"174","author":"McKallip","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0435","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0301-472X(01)00779-2","article-title":"Leukemic predisposition of pSca-1\/Cb2 transgenic mice","volume":"30","author":"Joosten","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0440","doi-asserted-by":"crossref","first-page":"39480","DOI":"10.1074\/jbc.M603495200","article-title":"Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1\/2 leading to G1 cell cycle arrest","volume":"281","author":"Sarfaraz","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2017.02.023_bib0445","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.bjc.6605248","article-title":"Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-methanandamide and JWH-015: involvement of CB2","volume":"101","author":"Olea-Herrero","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0450","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0455","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bone.2010.07.015","article-title":"Advances in the biology of bone metastasis: how the skeleton affects tumor behavior","volume":"48","author":"Sterling","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2017.02.023_bib0460","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/ijc.26031","article-title":"The seed and soil hypothesis revisited \u2013 the role of tumor-stroma interactions in metastasis to different organs","volume":"128","author":"Langley","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.02.023_bib0465","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/8756-3282(91)90059-R","article-title":"Incidence, prevalence and distribution of bone metastases","volume":"12","author":"Tubiana-Hulin","year":"1991","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2017.02.023_bib0470","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.02.023_bib0475","first-page":"92","article-title":"Epidemiology and classification of bone tumors","volume":"9","author":"Franchi","year":"2012","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"10.1016\/j.phrs.2017.02.023_bib0480","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.clinthera.2009.05.009","article-title":"Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials","volume":"31","author":"Machado","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.phrs.2017.02.023_bib0485","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2010.227","article-title":"Bone metastasis: mechanisms and therapeutic opportunities","volume":"7","author":"Suva","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0490","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","article-title":"Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy","volume":"10","author":"Kozlow","year":"2005","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.phrs.2017.02.023_bib0495","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0500","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/cncr.20756","article-title":"Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy","volume":"103","author":"van der Linden","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0505","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/bonekey.2013.112","article-title":"Targeted therapies for bone sarcomas","volume":"2","author":"Heymann","year":"2013","journal-title":"BoneKEy Rep."},{"key":"10.1016\/j.phrs.2017.02.023_bib0510","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrc1528","article-title":"Osteoblasts in prostate cancer metastasis to bone","volume":"5","author":"Logothetis","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0515","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic mechanisms responsible for osteolytic and osteoblastic bone metastases","volume":"12","author":"Guise","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0520","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/cncr.24896","article-title":"Pathogenesis of osteoblastic bone metastases from prostate cancer","volume":"116","author":"Ibrahim","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0525","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y","article-title":"Molecular mechanisms of osteolytic bone metastases","volume":"88","author":"Guise","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0530","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.acthis.2007.12.002","article-title":"Breast adenocarcinoma mcf-7 cell line induces spontaneous osteoclastogenesis via a rank-ligand-dependent pathway","volume":"110","author":"Nicolin","year":"2008","journal-title":"Acta Histochem."},{"key":"10.1016\/j.phrs.2017.02.023_bib0535","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10555-006-9023-1","article-title":"Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases","volume":"25","author":"Siclari","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.phrs.2017.02.023_bib0540","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: mechanisms of bone loss","volume":"12","author":"Chen","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0545","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2004.11.070","article-title":"Crosstalk between cancer cells and bone microenvironment in bone metastasis","volume":"328","author":"Yoneda","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2017.02.023_bib0550","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/bonekey.2012.96","article-title":"The role of tgf-beta in bone metastasis: novel therapeutic perspectives","volume":"1","author":"Buijs","year":"2012","journal-title":"BoneKEy Rep."},{"key":"10.1016\/j.phrs.2017.02.023_bib0555","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1677\/ERC-09-0012","article-title":"Mechanisms of bone metastases of breast cancer","volume":"16","author":"Suva","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0560","doi-asserted-by":"crossref","first-page":"6305s","DOI":"10.1158\/1078-0432.CCR-06-1157","article-title":"Future treatment of bone metastases","volume":"12","author":"Lipton","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0565","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1158\/0008-5472.CAN-05-4566","article-title":"\u03949-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation","volume":"66","author":"Caffarel","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0570","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1158\/1535-7163.MCT-09-0448","article-title":"Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer","volume":"8","author":"Qamri","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2017.02.023_bib0575","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1158\/1535-7163.MCT-07-0371","article-title":"Cannabidiol as a novel inhibitor of id-1 gene expression in aggressive breast cancer cells","volume":"6","author":"McAllister","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2017.02.023_bib0580","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-04-3410","article-title":"Cannabinoid receptor as a novel target for the treatment of prostate cancer","volume":"65","author":"Sarfaraz","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0585","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/1535-7163.MCT-12-0335","article-title":"Cox-2 and ppar-gamma confer cannabidiol-induced apoptosis of human lung cancer cells","volume":"12","author":"Ramer","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2017.02.023_bib0590","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1038\/onc.2008.145","article-title":"Jund is involved in the antiproliferative effect of \u03949-tetrahydrocannabinol on human breast cancer cells","volume":"27","author":"Caffarel","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2017.02.023_bib0595","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1158\/0008-5472.CAN-04-3136","article-title":"2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion","volume":"64","author":"Nithipatikom","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0600","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yexcr.2005.10.024","article-title":"Anandamide inhibits adhesion and migration of breast cancer cells","volume":"312","author":"Grimaldi","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0605","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1158\/1940-6207.CAPR-10-0181","article-title":"Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis","volume":"4","author":"Preet","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0610","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14712\/fb2012058020075","article-title":"Anti-proliferative and anti-angiogenic effects of CB2R agonist (JWH-133) in non-small lung cancer cells (A549) and human umbilical vein endothelial cells: an in vitro investigation","volume":"58","author":"Vidinsky","year":"2012","journal-title":"Folia Biol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0615","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jnci\/djm268","article-title":"Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1","volume":"100","author":"Ramer","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phrs.2017.02.023_bib0620","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.bcp.2009.11.007","article-title":"Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1","volume":"79","author":"Ramer","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0625","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.onc.1210641","article-title":"\u03949-tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo","volume":"27","author":"Preet","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2017.02.023_bib0630","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1096\/fj.02-0795fje","article-title":"Inhibition of tumor angiogenesis by cannabinoids","volume":"17","author":"Blazquez","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2017.02.023_bib0635","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0640","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jbmr.1732","article-title":"Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists","volume":"28","author":"Lozano-Ondoua","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0645","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bjp.0706838","article-title":"In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?","volume":"149","author":"Yao","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0650","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3565(25)20744-3","article-title":"Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands","volume":"278","author":"Showalter","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2017.02.023_bib0655","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tox.2006.11.005","article-title":"Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells","volume":"231","author":"Hsu","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.phrs.2017.02.023_bib0660","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7150\/ijbs.8337","article-title":"Involvement of par-4 in cannabinoid-dependent sensitization of osteosarcoma cells to trail-induced apoptosis","volume":"10","author":"Notaro","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2017.02.023_bib0665","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2017.02.023_bib0670","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI37948","article-title":"Cannabinoid action induces autophagy-mediated cell death through stimulation of er stress in human glioma cells","volume":"119","author":"Salazar","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2017.02.023_bib0675","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1038\/cddis.2013.151","article-title":"Cannabinoids inhibit energetic metabolism and induce ampk-dependent autophagy in pancreatic cancer cells","volume":"4","author":"Dando","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2017.02.023_bib0680","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3892\/ol.2015.3525","article-title":"Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid win-55,212-2","volume":"10","author":"Niu","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phrs.2017.02.023_bib0685","doi-asserted-by":"crossref","first-page":"e23901","DOI":"10.1371\/journal.pone.0023901","article-title":"Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion","volume":"6","author":"Nasser","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phrs.2017.02.023_bib0690","first-page":"46","article-title":"The role of chemokine receptor CXCR4 in breast cancer metastasis","volume":"3","author":"Mukherjee","year":"2013","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0695","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4161\/cbt.7.11.7218","article-title":"New insights into the role of CXCR4 in prostate cancer metastasis","volume":"7","author":"Gladson","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.phrs.2017.02.023_bib0700","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10555-006-9019-x","article-title":"The pivotal role of CXCL12 (SDF-1)\/CXCR4 axis in bone metastasis","volume":"25","author":"Wang","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.phrs.2017.02.023_bib0705","first-page":"147","article-title":"Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management","volume":"5","author":"Leyva-Illades","year":"2013","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0710","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/onc.2010.402","article-title":"The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK","volume":"30","author":"Andradas","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2017.02.023_bib0715","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/onc.2010.417","article-title":"The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation","volume":"30","author":"Pineiro","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2017.02.023_bib0720","doi-asserted-by":"crossref","first-page":"16511","DOI":"10.1073\/pnas.0902743106","article-title":"The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo","volume":"106","author":"Whyte","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2017.02.023_bib0725","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tips.2009.11.008","article-title":"Receptor heteromerization and drug discovery","volume":"31","author":"Rozenfeld","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2017.02.023_bib0730","doi-asserted-by":"crossref","first-page":"21960","DOI":"10.1074\/jbc.M114.561761","article-title":"Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling","volume":"289","author":"Moreno","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2017.02.023_bib0735","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2001.19.15.3562","article-title":"Biology of osteoclast activation in cancer","volume":"19","author":"Roodman","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.02.023_bib0740","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/8756-3282(91)90057-P","article-title":"Mechanisms of osteolytic bone destruction","volume":"12","author":"Mundy","year":"1991","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2017.02.023_bib0745","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.lfs.2010.02.014","article-title":"A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss","volume":"86","author":"Lozano-Ondoua","year":"2010","journal-title":"Life Sci."},{"issue":"Pt A","key":"10.1016\/j.phrs.2017.02.023_bib0750","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2013.08.003","article-title":"Cancer-induced bone pain: mechanisms and models","volume":"557","author":"Lozano-Ondoua","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.02.023_bib0755","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.pain.2013.07.044","article-title":"Bone cancer pain: causes, consequences, and therapeutic opportunities","volume":"154","author":"Mantyh","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2017.02.023_bib0760","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"key":"10.1016\/j.phrs.2017.02.023_bib0765","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jpain.2010.12.016","article-title":"Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers","volume":"12","author":"Bloom","year":"2011","journal-title":"J. Pain"},{"key":"10.1016\/j.phrs.2017.02.023_bib0770","doi-asserted-by":"crossref","first-page":"14649","DOI":"10.1523\/JNEUROSCI.3300-10.2010","article-title":"Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain","volume":"30","author":"Jimenez-Andrade","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2017.02.023_bib0775","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1200\/JCO.2013.51.7219","article-title":"Pain and nociception: mechanisms of cancer-induced bone pain","volume":"32","author":"Falk","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0780","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","article-title":"Macrophages: obligate partners for tumor cell migration, invasion, and metastasis","volume":"124","author":"Condeelis","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2017.02.023_bib0785","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/0008-5472.CAN-07-0912","article-title":"Tumor-associated macrophages press the angiogenic switch in breast cancer","volume":"67","author":"Lin","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0790","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1593\/neo.09988","article-title":"The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment","volume":"11","author":"Mizutani","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.phrs.2017.02.023_bib0795","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.nurt.2009.08.002","article-title":"Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside","volume":"6","author":"Rahn","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2017.02.023_bib0800","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.phrs.2017.02.023_bib0805","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1073\/pnas.1834309100","article-title":"Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the cns","volume":"100","author":"Ibrahim","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2017.02.023_bib0810","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/3-540-26573-2_17","article-title":"Cannabinoid mechanisms of pain suppression","author":"Walker","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0815","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cbdv.200790150","article-title":"Cannabis, pain, and sleep: lessons from therapeutic clinical trials of sativex, a cannabis-based medicine","volume":"4","author":"Russo","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.phrs.2017.02.023_bib0820","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/TCRM.S79409","article-title":"The unsolved case of \u201cbone-impairing analgesics\u201d: the endocrine effects of opioids on bone metabolism","volume":"11","author":"Coluzzi","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.phrs.2017.02.023_bib0825","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/09298673113206660296","article-title":"Recent development of CB2 selective and peripheral CB1\/CB2 cannabinoid receptor ligands","volume":"21","author":"Nevalainen","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2017.02.023_bib0830","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/sj.bjp.0707568","article-title":"In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models","volume":"153","author":"Yao","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0835","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1471-4892(02)00004-8","article-title":"CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?","volume":"3","author":"Malan","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0840","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00210-008-0386-4","article-title":"Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain","volume":"379","author":"Leichsenring","year":"2009","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0845","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1129-2377-15-14","article-title":"Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model","volume":"15","author":"Greco","year":"2014","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.phrs.2017.02.023_bib0850","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phrs.2011.03.007","article-title":"Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain","volume":"64","author":"Khasabova","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2017.02.023_bib0855","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1007\/s10753-015-0168-3","article-title":"Intrathecal injection of jwh-015 attenuates bone cancer pain via time-dependent modification of pro-inflammatory cytokines expression and astrocytes activity in spinal cord","volume":"38","author":"Lu","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.phrs.2017.02.023_bib0860","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157015907780866884","article-title":"The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration","volume":"5","author":"Ashton","year":"2007","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0865","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1476-5381.2009.00629.x","article-title":"Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain","volume":"160","author":"Curto-Reyes","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0870","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1073\/pnas.0409888102","article-title":"CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids","volume":"102","author":"Ibrahim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2017.02.023_bib0875","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0714.2006.00360.x","article-title":"Pathogenesis of bone metastasis: a review","volume":"35","author":"Raubenheimer","year":"2006","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.phrs.2017.02.023_bib0880","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.phrs.2017.02.023_bib0885","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1200\/JCO.2005.02.9579","article-title":"Bisphosphonates for treatment and prevention of bone metastases","volume":"23","author":"Michaelson","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0890","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta8040","article-title":"A systematic review of the role of bisphosphonates in metastatic disease","volume":"8","author":"Ross","year":"2004","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.phrs.2017.02.023_bib0900","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1185\/03007995.2015.1105795","article-title":"A comprehensive review of denosumab for bone metastasis in patients with solid tumors","volume":"32","author":"Gul","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.phrs.2017.02.023_bib0905","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.bjp.0706632","article-title":"Cannabinoids and cancer: pros and cons of an antitumour strategy","volume":"148","author":"Bifulco","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0910","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156802608783498014","article-title":"Recent advances in the development of selective ligands for the cannabinoid CB2 receptor","volume":"8","author":"Marriott","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.phrs.2017.02.023_bib0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.109.060251","article-title":"Ligand- and heterodimer-directed signaling of the CB1 cannabinoid receptor","volume":"77","author":"Hudson","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.023_bib0920","doi-asserted-by":"crossref","first-page":"e29239","DOI":"10.1371\/journal.pone.0029239","article-title":"Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons","volume":"7","author":"Rozenfeld","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phrs.2017.02.023_bib0925","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.bone.2010.01.368","article-title":"The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo","volume":"46","author":"Idris","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2017.02.023_bib0930","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.18632\/oncotarget.2233","article-title":"Cannabinoids as therapeutic agents in cancer: current status and future implications","volume":"5","author":"Chakravarti","year":"2014","journal-title":"Oncotarget"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816313809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816313809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T01:56:40Z","timestamp":1750039000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816313809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":186,"alternative-id":["S1043661816313809"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.02.023","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}